What does IBERIA PHARMACEUTICALS INDIA LIMITED do?

DRHP Filed — Dates AwaitedMAINBOARDOfficial SEBI Filing

IBERIA PHARMACEUTICALS INDIA LIMITED

Price Band

—

Total Issue Size

—

Bidding Window

—

Market Lot

—

Subscription

—

Issue Timeline & Lifecycle

DRHP Filed

17 Sept 2026

Issue Opens

Not announced

Issue Closes

Not announced

Allotment

Not announced

Exchange Debut

Not announced

DRHP Filed

17 Sept 2026

Issue Opens

Not announced

Issue Closes

Not announced

Allotment

Not announced

Exchange Debut

Not announced

AI Company Profile

AI Snapshot

IBERIA PHARMACEUTICALS INDIA LIMITED IPO

Founded:2013HQ:Unit No. 304-305, 3rd Floor Tower-B, Global Business Park MG Road, DLF QE, Gurgaon, Haryana, India, 122002

What Looks Strong

The offer document states no strength that could be verified.

What to Watch

The offer document states no risk factor that could be verified.

Fundamentals & Key Metrics

Period:FY26

Profitability & Returns

6 items

EBITDA Marginℹ

19.34%

Profit Marginℹ

11.53%

RoNWℹ

21.55%

ROCEℹ

23.69%

Basic EPSℹ

₹5.73

Book Valueℹ

₹26.59

Financial Health & Solvency

4 items

Debt/Equityℹ

0.37x

Net Worthℹ

₹51.65 Cr

Total Debtℹ

₹19.28 Cr

Operating Cash Flowℹ

₹11.03 Cr

Financials at a glance

Restated Consolidated

Statement: Income StatementPeriod: Restated Multi-Year (FY)

Shareholding, Ownership & Dilution

4 disclosed holders

Pre-Offer Shareholding Distribution

Breakdown of major disclosed shareholders prior to the issue

100.00% Pre-Issue

100%Pre-Offer

Shivani Jain

54.04%

Nitin Jain

25.77%

Rishabh Jain

9.74%

Saurav Ojha

6.89%

Others

3.56%

Ownership Impact of the IPO

What is newly issued, what changes hands, and what stays put

The capital base is disclosed, but the offer is not priced and no complete offered-share count is available yet. A percentage would be speculative at this stage.

Disclosed Pre-Offer Shareholders Table

AI Summary

Filing-backed

Prospectus Research

Analyze business model, competitive strengths, use of issue proceeds, and disclosed risk factors with official page citations.

Issue intermediaries

Listing venues

NSE,BSE

Listed Peer Valuation & Returns

Industry Avg P/E:53.87x

Swipe left / right to view all valuation metrics→

Company
Eris Lifesciences Limited	₹1,335	29.45x	₹3.13K Cr	₹281.64
Torrent Pharmaceuticals Limited	₹5,004	78.29x	₹13.98K Cr	₹247.87
Financial year 2026(4) Iberia Pharmaceuticals India Limited	—	—	₹96.54 Cr	₹26.59

Official Prospectus Filings

IBERIA PHARMACEUTICALS INDIA LIMITED - DRHP IBERIA PHARMACEUTICALS INDIA LIMITED- Draft Abridged Prospectus

Type: DRHP · Published: 2026-09-17

IBERIA PHARMACEUTICALS INDIA LIMITED IPO — Dates, Price Band, Lot Size, Financials & Prospectus Analysis | Anvest

IBERIA PHARMACEUTICALS INDIA LIMITED

Issue Timeline & Lifecycle

What Looks Strong

What to Watch

Profitability & Returns

Financial Health & Solvency

Disclosed Pre-Offer Shareholders Table

AI Summary

Prospectus Research

Issue intermediaries

Listed Peer Valuation & Returns

Official Prospectus Filings

Frequently Asked Questions